The Spanish Agency of Medicines and Health Products (AEMPS) has taken decisive action against the product known as "Néctar del Amor," an aphrodisiac drink that has been circulating in the market without proper authorization. The agency has prohibited its sale and ordered the withdrawal of all units, citing serious health concerns due to the presence of sildenafil, a prescription-only medication commonly known under the brand name "Viagra."
"Néctar del Amor" had been promoted as a natural enhancer of sexual function, but analyses conducted by the Official Control Laboratory of the AEMPS revealed a different story. The laboratory confirmed that the product contains sildenafil in quantities sufficient to "restore, correct or modify" physiological functions by exerting a pharmacological action. This discovery legally classifies "Néctar del Amor" as a medication, which requires rigorous evaluation and authorization processes that it had not undergone.
Sildenafil is a potent active ingredient indicated for the treatment of erectile dysfunction. It works by increasing blood flow to the penis through the selective inhibition of phosphodiesterase type 5 (PDE-5). While effective when used correctly, sildenafil must be prescribed by a healthcare professional due to its potential interactions and contraindications.
One of the primary concerns raised by the AEMPS is that sildenafil does not appear on the label of "Néctar del Amor." Instead, the product misleadingly lists a series of vitamins and minerals, providing false information about its safety. This lack of transparency poses risks to consumers who may unknowingly ingest a potent medication without understanding the potential consequences.
Consuming "Néctar del Amor" can cause serious health issues, particularly cardiovascular problems. The product presents numerous interactions with other medications, which can lead to adverse reactions. These reactions have been observed more frequently in patients with a history of cardiovascular risk factors, for whom sildenafil is contraindicated.
According to the AEMPS, PDE-5 inhibitors like sildenafil are contraindicated in patients with acute myocardial infarction, unstable angina, effort angina, heart failure, uncontrolled arrhythmias, hypotension, uncontrolled hypertension, and a history of non-arteritic anterior ischemic optic neuropathy. Additionally, individuals with hereditary degenerative retinal disorders such as retinitis pigmentosa are advised against using such medications.
Adverse reactions associated with the consumption of products containing sildenafil without medical supervision have included acute myocardial infarction, unstable angina, ventricular arrhythmia, palpitations, tachycardia, cerebrovascular accidents, and even sudden cardiac death. The risk is further heightened when consumers are unaware of the presence of sildenafil in the product.
The precautionary measure by the AEMPS came after being informed by the Police of Navarra about the marketing of "Néctar del Amor." The agency emphasized that the pharmacological action of the product confers it the legal status of a medicine, which necessitates strict regulatory compliance to ensure consumer safety.
The AEMPS has urged consumers who may have purchased "Néctar del Amor" to refrain from using it and to consult healthcare professionals if they have experienced any adverse effects. The agency's swift action reflects its commitment to safeguarding public health by preventing unauthorized medicinal products from endangering consumers.
Produced with the assistance of a news-analysis system.